Trial Profile
Fenofibrate effects on endothelial progenitor cell (EPC) number and function in patients with recent diagnosis of type 2 diabetes mellitus (T2DM).
Status:
Not yet recruiting
Phase of Trial:
Phase I
Latest Information Update: 22 Jun 2016
Price :
$35
*
At a glance
- Drugs Atorvastatin (Primary) ; Fenofibrate (Primary)
- Indications Hypercholesterolaemia
- Focus Pharmacodynamics
- 22 Jul 2011 New trial record